Table 2. Demographics, duration of the disease and DLQI scores by Hurley Stage of HS patients enrolled in the HS severity questionnaire validation study.
| Hurley Stage | |||||
|---|---|---|---|---|---|
| I (Mild) (N = 39) |
II (Moderate) (N = 43) |
III (Severe) (N = 35) |
All (N = 117) |
||
| Age at enrollment (Years) |
Mean (SD) | 36.7 (13.5) | 39.6 (13.7) | 42.3 (14.1) | 39.4 (13.8) |
| Median | 32.4 | 35.4 | 44.0 | 36.1 | |
| Min, Max | 19.3, 68.7 | 19.6, 71.8 | 18.1, 70.5 | 18.1, 71.8 | |
| Gender | Male | 12 (30.8%) | 14 (32.6%) | 13 (37.1%) | 39 (33.3%) |
| Female | 27 (69.2%) | 29 (67.4%) | 22 (62.9%) | 78 (66.7%) | |
| Duration of HS Symptoms | Less than 12 months | 3 (7.7%) | 2 (4.7%) | 0 (0.0%) | 5 (4.3%) |
| 12 months to 5 years | 15 (38.5%) | 6 (14.0%) | 4 (11.4%) | 25 (21.4%) | |
| 5 to 10 years | 9 (23.1%) | 10 (23.3%) | 5 (14.3%) | 24 (20.5%) | |
| 10 years or longer | 12 (30.8%) | 25 (58.1%) | 26 (74.3%) | 63 (53.8%) | |
| Length of HS Time since HS diagnosis | Less than 12 months | 14 (35.9%) | 3 (7.0%) | 4 (11.4%) | 21 (17.9%) |
| 12 months to 5 years | 10 (25.6%) | 19 (44.2%) | 6 (17.1%) | 35 (29.9%) | |
| 5 to 10 years | 11 (28.2%) | 6 (14.0%) | 7 (20.0%) | 24 (20.5%) | |
| 10 years or longer | 4 (10.3%) | 15 (34.9%) | 18 (51.4%) | 37 (31.6%) | |
| Total DLQI scores | Mean (SD) | 10.3 (7.7) | 10.5 (7.9) | 15.0 (8.2) | 11.8 (8.1) |
| Median | 9.0 | 8.0 | 12.0 | 10.0 | |
| Min, Max | 0.0, 28.0 | 0.0, 28.0 | 2.0, 30.0 | 0.0, 30.0 | |